Lorena Fraga - Profile and Journalist Details

Find journalists that align with your industry, location and vision. Unlock Lorena Fraga's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.

Get connected with journalists today
Lorena Fraga

Lorena Fraga

Verified

Reporter, G1

Brasília

Biography

Estagiária de jornalismo na @arkoadvice | Antes no @Poder360 e @correio | | Jornalismo na UnB | ex-@sosimprensa

Final Covers

Mundo Política Economia

Doesn’t Cover

Anything that isn't sport.

Journalist Type

Seniority Positions

Industries

Medium Formats

Content

Total articles 26

  • Mulheres ainda têm pouca representação em cargos-chave nos partidos, apontam especialistas e parlamentares

    By Elisa Clavery, Lorena Fraga Verified

    Mar. 08, 2025

  • Calorão: sistema de energia elétrica registra nesta sexta quarto recorde de consumo em 2025

    By Lorena Fraga Verified

    Feb. 21, 2025

  • Mulheres ainda têm pouca representação em cargos-chave nos partidos, apontam especialistas e parlamentares

    By Elisa Clavery, Lorena Fraga Verified

    Mar. 08, 2025

As seen in

Company Info

G1

G1 Therapeutics, Inc. is a biopharmaceutical company based in Research Triangle Park, North Carolina. Founded in 2008, it focuses on developing small molecule therapies for cancer treatment. The company aims to improve patient outcomes by targeting cellular pathways involved in cancer progression. G1 Therapeutics became a subsidiary of Pharmacosmos A/S in September 2024. The company's flagship product, COSELA (trilaciclib), is an FDA-approved drug that protects bone marrow from chemotherapy damage. It is administered intravenously before chemotherapy to enhance patient safety. G1 Therapeutics also has a pipeline that includes lerociclib, a CDK4/6 inhibitor, and other investigational compounds aimed at cancer treatment. The company collaborates with organizations like GeneCentric Therapeutics and AstraZeneca to advance its research and clinical trials.

, ,

'+1 919-213-9835

Founded: 2008